L
Laurus Labs
An innovation-driven¸ people-centric & client-focused organization offering a broad and integrated portfolio of products & services to the global pharmaceutical industry
At a glance
- Status
- Listed
- Listing
- IPO 2016
Open roles
Laurus Labs in the Hyderabad ecosystem
The Laurus Labs office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Series B and later1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Investments and acquisitions
Disclosed deals where Laurus Labs was the backer or acquirer, 2020–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
4 deals across Laurus Labs's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Laurus Labs's portfolio, mapped.
See Laurus Labs on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
Laurus Labs buys 60% of Canada's Galenvs for $3.75M to expand oligonucleotides
BDR Pharma buys Acme's oral solids arm to scale its CDMO platform
Laurus Labs pumps $11.3M into KRKA Pharma joint venture



